How It Works Open Source Health Books Consultations Start Your Map

Open Source Health · Chronic Pain

Chronic pain is not a structural
problem. It is a nervous system
problem.

When pain persists long after tissue has healed, the injury is no longer the story. The nervous system has learned pain. This is what that means, why management keeps failing, and what restoration actually looks like when you stop chasing the injury.

The MRI shows a finding.
The finding may not be
causing what you feel.

Pain that persists is the nervous system
running a program it cannot stop.

Acute pain is a signal. Tissue is damaged, nociceptors fire, the signal travels to the brain, the brain generates the experience of pain to motivate protective behavior. This is the system working correctly. Heal the tissue, the signal stops.

Chronic pain is different. After approximately 3 to 6 months of persistent pain signaling, the nervous system undergoes structural and functional changes. Pain neurons become more sensitive. They fire more easily. They fire in response to stimuli that should not produce pain. The threshold for activating a pain response drops. This process is called central sensitization, and it is one of the most important concepts in understanding why pain persists long after the original injury has resolved.

In a sensitized nervous system, the MRI finding, the disc herniation, the arthritis, the worn cartilage, may not be the primary driver of pain. Studies consistently show poor correlation between structural findings and pain experience. People with severe structural findings feel no pain. People with minimal structural findings are disabled by pain. The nervous system's interpretation of the signal matters more than the signal itself.

Allostatic load, the cumulative burden of biological stress on the system, also directly affects pain sensitivity. Chronic sleep deprivation, emotional stress, unresolved trauma, gut inflammation, and nutrient deficiencies all lower the pain threshold by keeping the nervous system in a state of high alert. This is why pain almost always worsens during stressful periods and why treating pain without addressing these drivers produces partial results at best.

Peripheral Sensitization

Local tissue becomes hypersensitive

After injury or prolonged inflammation, local pain receptors lower their activation threshold. They fire with less stimulus. This is the body protecting damaged tissue. In chronic pain, this process persists after tissue healing and is maintained by ongoing local inflammation.

Central Sensitization

The spinal cord and brain amplify the signal

Chronic pain signaling causes changes in the dorsal horn of the spinal cord and in brain pain processing areas. The amplification system becomes hyperactive. Non-painful stimuli produce pain. Pain from one area spreads to adjacent areas. The nervous system has learned to produce pain even without a clear ongoing tissue source.

Neuroplastic Change

The brain physically changes in response to chronic pain

Chronic pain shrinks gray matter in the prefrontal cortex and increases activity in pain-processing networks. These are measurable structural changes. The good news: neuroplasticity works in both directions. The brain can unlearn pain as effectively as it learned it, given the right conditions.

Allostatic Load

Everything lowers the threshold

Sleep deprivation, stress, trauma, inflammation, nutritional deficiency, and social isolation all reduce the nervous system's pain threshold. Chronic pain rarely exists in isolation. It exists in a context. That context is almost always part of the problem and must be part of the solution.

Management keeps you functional.
Restoration gives your nervous system
the conditions to recalibrate.

The standard approach treats
the signal, not the system.

Western medicine's primary tools for chronic pain are structural interventions (surgery, injections) and pharmaceutical management (opioids, NSAIDs, nerve agents). Both can provide meaningful relief in appropriate contexts. Both are widely misapplied to conditions that are primarily nervous system problems rather than structural ones.

The Opioid Cascade

Long-term opioid therapy for non-cancer chronic pain produces more suffering than it resolves

The evidence on long-term opioid therapy for chronic non-cancer pain is unambiguous: it does not improve function, does not reduce pain long-term due to tolerance and opioid-induced hyperalgesia, and significantly increases the risk of dependence, overdose, and worsening pain sensitivity. Opioid-induced hyperalgesia is a real phenomenon where opioid use itself lowers the pain threshold, creating a cycle where more drug produces more pain sensitivity rather than less. Millions of people are in this cycle right now and most of them were never told it was a known consequence.

Structural Fixation

Treating MRI findings as the diagnosis when they may not be the cause

Approximately 80 percent of people over 50 have disc abnormalities on MRI. The majority have no pain. When someone with chronic low back pain gets an MRI and sees a bulging disc, they are told that is the cause. It may not be. Studies comparing surgery for back pain to conservative care show minimal long-term difference in outcomes for most presentations. The structural finding gets treated. The sensitized nervous system does not. The pain continues and is now attached to a structural explanation that makes it feel permanent.

Ignoring Central Sensitization

Conditions like fibromyalgia, chronic widespread pain, and CRPS are nervous system conditions treated as local tissue problems

Fibromyalgia is central sensitization. The evidence on this is not contested in pain research, only in general clinical practice. The widespread tender points, the allodynia, the fatigue, and the sleep disruption are all features of a sensitized central nervous system. Prescribing local treatments for a central problem produces local results at best. The nervous system calibration is never addressed. The condition never meaningfully improves.

Long-term NSAID Use

Anti-inflammatory medications used chronically cause the very inflammation they suppress

NSAIDs block cyclooxygenase enzymes to reduce prostaglandin production. Short-term this reduces inflammation and pain. Long-term, chronic NSAID use damages the gut lining, creates intestinal permeability, and drives systemic inflammation. It also suppresses the prostaglandins that protect the stomach lining, causing ulceration and bleeding. Taking a drug that damages the gut to suppress inflammation that is partly driven by gut damage is a cycle. Millions of people are in it daily without understanding the mechanism.

Trauma Is Not Addressed

Adverse childhood experiences and unresolved trauma are among the strongest predictors of chronic pain

The ACE (Adverse Childhood Experiences) studies documented a direct dose-response relationship between early trauma and chronic pain in adulthood. Unresolved trauma keeps the nervous system in a chronic threat state. A nervous system that cannot come down from high alert is a nervous system with a lowered pain threshold, heightened inflammatory signaling, and disrupted sleep. None of these are addressed by surgery, opioids, or NSAIDs. This is the piece that most pain management programs do not ask about and almost never treat.

The type of pain tells you
where to look first.

Chronic pain has multiple distinct presentations with different upstream drivers. Matching the intervention to the type matters more than trying one thing and calling it treatment-resistant when it fails.

Pattern One

Localized pain with a clear origin. Worsens with activity, improves with rest.

  • Ongoing local inflammation from structural issue
  • Peripheral sensitization from repeated injury
  • Pro-inflammatory diet amplifying local response
  • Inadequate tissue recovery between stress episodes
  • Nutritional deficiencies (magnesium, omega-3, vitamin D)
  • Biomechanical compensation creating secondary pain
Pattern Two

Widespread pain. No clear injury. Worsens with stress, improves with rest and connection.

  • Central sensitization (fibromyalgia pattern)
  • Unresolved trauma and chronic threat state
  • Sleep deprivation lowering pain threshold
  • Systemic inflammation from gut dysbiosis
  • Cortisol dysregulation maintaining nervous system arousal
  • Social isolation amplifying pain perception
  • Prior or current opioid use inducing hyperalgesia
Pattern Three

Burning, electric, shooting pain. Often follows nerves. Worsens at night.

  • Peripheral neuropathy from metabolic causes (diabetes, B12 deficiency)
  • Nerve compression from structural issues
  • Post-herpetic neuralgia following shingles
  • Small fiber neuropathy (often undiagnosed)
  • Inflammatory neuropathy from autoimmune activity
  • Toxic neuropathy from medication or environmental exposure

The nervous system learned pain.
The nervous system can unlearn it.
This is not a metaphor. It is neuroscience.

Give the nervous system the conditions
it needs to recalibrate.

No single intervention resolves chronic pain. It is a system problem requiring a system approach. These tools address different pieces of the mechanism. The most effective strategies combine nervous system regulation, anti-inflammatory inputs, and where applicable, trauma resolution.

Pain Neuroscience Education

Understanding pain changes pain

Studies consistently show that educating people with chronic pain about the neuroscience of central sensitization produces measurable reductions in pain and disability, without any other intervention. Understanding that the pain is the nervous system's output rather than evidence of ongoing damage changes the threat assessment. A less threatening signal produces less pain. This is not telling people the pain is not real. It is changing the story the brain assigns to the signal.

Magnesium

NMDA receptor modulation reduces central sensitization

Magnesium blocks NMDA receptors, which are the primary drivers of central sensitization. Chronic pain states are associated with NMDA receptor overactivation. Magnesium glycinate or malate at 300 to 600mg daily provides meaningful NMDA modulation, reduces muscle tension, and improves sleep, all of which reduce pain burden. Deficiency is common and rarely tested. Intravenous magnesium for acute pain crises has documented efficacy in several pain conditions.

PEA (Palmitoylethanolamide)

Endogenous anti-inflammatory compound with strong neuropathic pain evidence

PEA is a fatty acid amide produced naturally in the body that modulates mast cell activation and neuroinflammation. It has an extensive evidence base for neuropathic pain, fibromyalgia, and chronic inflammatory conditions. It works through PPAR-alpha receptors to reduce inflammatory signaling at the nerve level. Dose: 600mg to 1,200mg daily. Effects build over 4 to 8 weeks. No significant side effects or drug interactions documented. Underused and underknown in conventional pain management.

Low Dose Naltrexone

Glial modulation and endorphin upregulation

At doses of 1.5 to 4.5mg (compared to the addiction treatment dose of 50mg), naltrexone transiently blocks opioid receptors, causing the body to upregulate endorphin production. It also modulates microglial activity, the immune cells of the brain that contribute to neuroinflammation and central sensitization. Evidence supports its use in fibromyalgia, Crohn's disease, multiple sclerosis, and complex regional pain syndrome. Requires a prescription. Compounding pharmacies prepare the low-dose form.

Requires physician prescribing. Not compatible with opioid therapy.

Graded Movement

Movement is medicine when dosed correctly

Complete rest maintains and worsens central sensitization. Movement, even gentle movement, sends the nervous system safety signals. It also produces endorphins, reduces inflammatory markers, and improves sleep. The principle is graded exposure: starting at a level that does not provoke a pain flare and incrementally increasing. Walking, swimming, and water-based exercise are typically well tolerated starting points. The goal is not exercise performance. It is nervous system recalibration through safe, consistent movement inputs.

Omega-3 Fatty Acids

Anti-inflammatory substrate for nervous system tissue

EPA and DHA directly compete with arachidonic acid for inflammatory enzyme sites, reducing the production of pro-inflammatory prostaglandins and leukotrienes. Neural tissue is largely composed of DHA. Adequate omega-3 status is required for normal nerve function and for the resolution of neuroinflammation. Therapeutic dose for pain conditions: 2 to 4g EPA/DHA combined daily. Sourced from high-quality fish oil or algae-based alternatives. Effects build over 8 to 12 weeks.

Somatic Therapy and Trauma Work

The body holds what the mind does not process

For people with chronic widespread pain, especially those with significant trauma history, somatic therapies (Somatic Experiencing, EMDR, Internal Family Systems) address the stored nervous system dysregulation that standard pain management never reaches. These are not "talking about feelings." They are structured approaches to discharging the physiological threat response that keeps the nervous system in a state that amplifies pain. The evidence base is growing and the mechanism is understood.

Sleep Restoration

Non-negotiable. Poor sleep is both a cause and consequence of chronic pain.

Sleep deprivation lowers the pain threshold directly and measurably. One night of inadequate sleep produces measurable increases in pain sensitivity the next day. Chronic sleep disruption is therefore both a driver of pain and something pain makes worse. Breaking the cycle requires treating sleep as a primary intervention, not an afterthought. See the Sleep guide for the full protocol. For pain specifically: magnesium glycinate before bed, addressing cortisol dysregulation, and prioritizing sleep architecture over sedation.

Anti-Inflammatory Nutrition

The diet is either driving or reducing systemic inflammation

Ultra-processed foods, refined sugar, seed oils, and excess alcohol all drive systemic inflammation that lowers the pain threshold and maintains peripheral sensitization. An anti-inflammatory dietary pattern (whole foods, adequate protein, olive oil, fatty fish, abundant vegetables, minimal processed carbohydrates) reduces inflammatory markers measurably within 6 to 8 weeks. For people with pain, diet is not optional background information. It is a direct input into the pain mechanism.

Curcumin

NF-kB inhibitor with meaningful anti-inflammatory evidence

Curcumin (the active compound in turmeric) inhibits NF-kB, one of the primary transcription factors driving inflammatory gene expression. Studies in osteoarthritis, inflammatory bowel conditions, and neuropathic pain show comparable effects to NSAIDs without gut damage. The critical factor is bioavailability: standard curcumin is poorly absorbed. Use phytosome, liposomal, or piperine-enhanced formulations. Dose: 500 to 1,000mg of a high-bioavailability form daily.

Questions people actually ask
about chronic pain.

I have been in pain for years. My MRI shows disc problems. Why isn't surgery fixing it?

Because the disc finding may not be the primary driver of your pain. Surgery addresses structure. If the primary problem is central sensitization, a sensitized nervous system that is generating pain independent of ongoing tissue damage, correcting the structure does not change the nervous system's program. The pain continues or migrates.

Studies on spinal surgery for chronic low back pain show that outcomes are highly dependent on patient selection. For people with clear, severe structural compromise (nerve root compression causing weakness, disc herniation with documented radiculopathy that has not responded to conservative care), surgery has better outcomes. For people with chronic widespread pain, diffuse symptoms, high distress, and poor sleep, surgery rarely produces sustained relief.

The more important question is whether your nervous system has been evaluated and treated, not just your spine. Central sensitization, sleep, inflammatory load, and psychological contributors to pain persistence are all part of the diagnosis. If none of those have been addressed, the conversation about surgery is incomplete.

My doctor is tapering my opioids and the pain is worse than ever. Is this normal?

Yes, and it has a name: opioid-induced hyperalgesia. Long-term opioid use sensitizes pain pathways rather than desensitizing them. When opioids are tapered or stopped, the hyperalgesia is unmasked. The pain that emerges may be more intense than the original pain that prompted the prescription. This is the opioid working against you.

This does not mean you should refuse a taper. It means the taper needs to be done slowly, with active support for the nervous system during the process. Magnesium, PEA, omega-3s, and sleep restoration can all help reduce the hyperalgesia burden during taper. Somatic therapy and nervous system regulation work are often critical during this period.

The taper will be uncomfortable. The nervous system needs time to recalibrate its pain threshold after long-term opioid exposure. That recalibration takes months. The outcome on the other side, for most people who complete it, is less pain and more function than they had on the opioids. That is not guaranteed but it is the documented pattern.

I have fibromyalgia. My doctor says there is nothing to do except medications. Is that true?

No. That reflects a significant gap in the treating physician's knowledge of the current evidence base. Fibromyalgia is one of the most studied central sensitization conditions and there is a meaningful body of evidence for non-pharmacological interventions.

Pain neuroscience education alone reduces pain and disability in fibromyalgia. Exercise, specifically graded aerobic exercise, is among the most evidence-supported treatments available. Sleep restoration directly reduces fibromyalgia symptom severity. Low dose naltrexone has shown benefit in clinical trials. Dietary modification reducing inflammatory load produces measurable improvements. Trauma-informed somatic therapy addresses the nervous system dysregulation that underlies many fibromyalgia presentations.

The medications most prescribed for fibromyalgia (pregabalin, duloxetine, milnacipran) have modest effects and significant side effect profiles. They are not unreasonable to try. They are not the only option, and they are rarely presented alongside the behavioral and nutritional interventions that have similar or better long-term outcomes.

I notice my pain is always worse when I am stressed. Is that psychological or physical?

It is physiological. The separation between psychological and physical is not meaningful at the biology level. Stress activates the sympathetic nervous system and the HPA axis. Cortisol and adrenaline rise. These hormones directly lower the pain threshold by sensitizing nociceptors and increasing inflammatory signaling. A nervous system in high-alert state is a nervous system that generates more pain from the same input.

The stress-pain connection is not weak. It is one of the strongest and most consistent relationships in pain research. It is also one of the least discussed in clinical pain management because the tools for addressing chronic stress (nervous system regulation, trauma resolution, sleep, social connection) are not billable procedures.

Acknowledging this connection does not mean the pain is not real. It means the stress is a real biological driver of the pain and addressing it is real treatment. Not instead of other approaches. In addition to them.

I have neuropathy in my feet. My doctor says nothing helps. What have I not tried?

Several things, depending on the cause of the neuropathy. The first question is what is causing it. Peripheral neuropathy has multiple drivers and the appropriate intervention depends entirely on the cause.

Diabetic neuropathy: blood sugar optimization is the primary intervention. Glucose-induced nerve damage is progressive when blood sugar is uncontrolled and partially reversible when it is controlled. Alpha lipoic acid at 600mg daily has documented evidence for symptom reduction in diabetic neuropathy. B12 deficiency neuropathy: methylcobalamin (active B12) at 1,000 to 5,000mcg daily, as deficiency is often functional rather than absolute and standard B12 tests may not capture it. Small fiber neuropathy: often missed on standard nerve conduction studies, requires skin punch biopsy for diagnosis. PEA has evidence specifically for small fiber neuropathy.

If the cause has never been fully investigated, that investigation is the starting point. Treating symptoms without knowing the cause produces results similar to treating pain without knowing the nervous system state: incomplete and often temporary.

Someone told me my pain is in my head. I am furious. But is there any truth to it?

The pain is real. The brain is where all pain is generated. That is not a dismissal. That is anatomy. Pain does not exist in the tissue. Pain is produced by the brain in response to signals from the tissue. In central sensitization, the brain produces pain even when the tissue signals are minimal or absent.

Saying pain is "in your head" as a dismissal is ignorant and harmful. But understanding that the brain is the generator of the pain experience is actually empowering, not dismissive. It means the brain can be targeted. Neuroplasticity works in both directions. The brain that learned to produce pain in response to minimal stimuli can, given the right conditions, unlearn that pattern.

The person who told you it was in your head probably meant "it is not real" or "it is psychological weakness." Both are wrong. The accurate version is: your nervous system has been reorganized by chronic pain signaling, and that reorganization can be addressed. That is a very different statement and a much more useful one.

Want to map the root
of your specific pain pattern?

The MAP Tool traces your situation to its origin. Not a guess. Not a label. The thread followed to where it actually leads.

Start Your Map